T₁ Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents

Area of Science:

• Neuroradiology
• Neuroimaging
• Magnetic Resonance Imaging (MRI)

Background:

• Contrast-enhanced MRI is a crucial diagnostic tool.
• Repeated administration of gadolinium-based contrast agents (GBCAs) is common in clinical practice.
• Long-term effects of cumulative GBCA exposure require further investigation.

Observation:

• A 34-year-old male presented with T1 shortening in cerebral cortices after over 86 contrast-enhanced MRI studies.
• High signal intensity (SI) was observed on T1-weighted images (T1WIs) in the globus pallidus, dentate nucleus, thalamic pulvinar, and cerebral cortices.
• These findings were not apparent on T1WIs from 11 years prior.

Findings:

• The observed high SI in cerebral cortices aligns with regions of normal iron deposition.
• This suggests a potential association between gadolinium deposition and the brain's iron metabolism.
• Gadolinium accumulation may alter T1 signal intensity in specific brain regions.

Implications:

• Findings raise concerns about the long-term safety of cumulative gadolinium exposure from contrast-enhanced MRI.
• Further research is needed to elucidate the mechanisms of gadolinium deposition and its clinical significance.
• This could impact future guidelines for GBCA administration and patient monitoring.